Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
ALLERGENIC EXTRACTSINDIVIDUAL TREATMENT VIAL
Medication labelWhy this: Advisory · dailymed-other
When the natural exposure to elevated aeroallergens produces symptoms as described under Clinical Pharmacology, specific diagnosis and therapeutic procedures are indicated. Clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. Diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. Specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. When immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. An orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 THIS PRODUCT IS NOT INTENDED FOR TREATMENT OF PATIENTS WHO DO NOT MANIFEST IMMEDIATE HYPERSENSITIVITY REACTIONS TO THE ALLERGENIC EXTRACT FOLLOWING SKIN TESTING.
- generic_name
- treatment set ts346889
- brand_name
- Treatment Set TS346962, Treatment Set TS347116, Treatment Set TS346963, Treatment Set TS346964, Treatment Set TS347115, Treatment Set TS347226, Treatment Set TS347227, Treatment Set TS347249, Treatment Set TS347250, Treatment Set TS347335, Treatment Set TS347336, Treatment Set TS347337, Treatment Set TS347338, Treatment Set TS347483, Treatment Set TS347484, Treatment Set TS347536, Treatment Set TS347537, Treatment Set TS347627, Treatment Set TS347628
- product_names
- Treatment Set TS346889, Treatment Set TS346962, Treatment Set TS347116, Treatment Set TS346963, Treatment Set TS346964, Treatment Set TS347115, Treatment Set TS347226, Treatment Set TS347227, Treatment Set TS347249, Treatment Set TS347250, Treatment Set TS347335, Treatment Set TS347336, Treatment Set TS347337, Treatment Set TS347338, Treatment Set TS347483, Treatment Set TS347484, Treatment Set TS347536, Treatment Set TS347537, Treatment Set TS347627, Treatment Set TS347628
- ndc
- 49288-0865, 49288-0865-3, 49288-0866, 49288-0866-3, 49288-0870, 49288-0870-3, 49288-0867, 49288-0867-3, 49288-0868, 49288-0868-3, 49288-0869, 49288-0869-3, 49288-0871, 49288-0871-3, 49288-0872, 49288-0872-3, 49288-0873, 49288-0873-3, 49288-0874, 49288-0874-3, 49288-0875, 49288-0875-3, 49288-0876, 49288-0876-3, 49288-0877, 49288-0877-3, 49288-0878, 49288-0878-3, 49288-0879, 49288-0879-3, 49288-0880, 49288-0880-3, 49288-0881, 49288-0881-3, 49288-0882, 49288-0882-3, 49288-0883, 49288-0883-3, 49288-0884, 49288-0884-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en